Ulrick Espelund

1.3k total citations
31 papers, 836 citations indexed

About

Ulrick Espelund is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Ulrick Espelund has authored 31 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Ulrick Espelund's work include Growth Hormone and Insulin-like Growth Factors (15 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cancer Risks and Factors (5 papers). Ulrick Espelund is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (15 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cancer Risks and Factors (5 papers). Ulrick Espelund collaborates with scholars based in Denmark, United States and Germany. Ulrick Espelund's co-authors include Jan Frystyk, Allan Flyvbjerg, Hans Ørskov, Jens Otto Lunde Jørgensen, Troels Krarup Hansen, Sanne Fisker, Niels Juul, Mads Rasmussen, Kurt Højlund and Henning Beck‐Nielsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Anesthesiology.

In The Last Decade

Ulrick Espelund

31 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrick Espelund Denmark	18	240	219	205	193	158	31	836
Syed Ali Imran Canada	18	482 2.0×	175 0.8×	142 0.7×	214 1.1×	169 1.1×	73	1.0k
B. Zietz Germany	20	292 1.2×	128 0.6×	302 1.5×	319 1.7×	170 1.1×	34	1.0k
Matthias Breidert Germany	14	191 0.8×	211 1.0×	148 0.7×	159 0.8×	146 0.9×	50	863
Min Jin Go South Korea	18	221 0.9×	62 0.3×	150 0.7×	111 0.6×	315 2.0×	34	1.1k
Dennis Heutling Germany	9	161 0.7×	282 1.3×	324 1.6×	242 1.3×	129 0.8×	17	1.2k
Sibel Güldiken Türkiye	19	342 1.4×	88 0.4×	168 0.8×	128 0.7×	123 0.8×	72	904
Karin Tømmerås Norway	13	63 0.3×	104 0.5×	197 1.0×	123 0.6×	129 0.8×	18	710
Vincenzo Cappiello Italy	19	501 2.1×	552 2.5×	392 1.9×	189 1.0×	94 0.6×	27	1.1k
Belinda Brooks Australia	17	317 1.3×	168 0.8×	332 1.6×	131 0.7×	99 0.6×	27	1.2k
Necati Bingöl Türkiye	18	179 0.7×	294 1.3×	252 1.2×	461 2.4×	113 0.7×	30	898

Countries citing papers authored by Ulrick Espelund

Since Specialization

Citations

This map shows the geographic impact of Ulrick Espelund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrick Espelund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrick Espelund more than expected).

Fields of papers citing papers by Ulrick Espelund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrick Espelund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrick Espelund. The network helps show where Ulrick Espelund may publish in the future.

Co-authorship network of co-authors of Ulrick Espelund

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrick Espelund. A scholar is included among the top collaborators of Ulrick Espelund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrick Espelund. Ulrick Espelund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jessen, Christian, et al.. (2024). Subpectineal obturator nerve block reduces opioid consumption after hip arthroscopy: a triple-blind, randomized, placebo-controlled trial. Regional Anesthesia & Pain Medicine. 50(9). 719–724. 2 indexed citations

Jessen, Christian, et al.. (2023). Efficacy of iliopsoas plane block for patients undergoing hip arthroscopy: a prospective, triple-blind, randomized, placebo-controlled trial. Regional Anesthesia & Pain Medicine. 50(1). 5–10. 4 indexed citations

Espelund, Ulrick, Jan Brink Valentin, Christian Fenger‐Eriksen, et al.. (2023). Standard Versus Individualized Blood Pressure Targets During Thrombectomy: A Randomized Controlled Pilot Trial. SHILAP Revista de lepidopterología. 3(6). e001027–e001027. 1 indexed citations

Mikkelsen, Irene Klærke, Ulrick Espelund, Hugo Angleys, et al.. (2021). Cerebral Macro- and Microcirculation during Ephedrine versus Phenylephrine Treatment in Anesthetized Brain Tumor Patients: A Randomized Clinical Trial Using Magnetic Resonance Imaging. Anesthesiology. 135(5). 788–803. 18 indexed citations

Lauritsen, Simon Meyer, Bo Thiesson, Marianne Johansson Jørgensen, et al.. (2021). The Framing of machine learning risk prediction models illustrated by evaluation of sepsis in general wards. npj Digital Medicine. 4(1). 158–158. 36 indexed citations

Mikkelsen, Irene Klærke, Joel Aanerud, Ulrick Espelund, et al.. (2020). Ephedrine versus Phenylephrine Effect on Cerebral Blood Flow and Oxygen Consumption in Anesthetized Brain Tumor Patients. Anesthesiology. 133(2). 304–317. 27 indexed citations

Hjortebjerg, Rikke, Ulrick Espelund, Torben Riis Rasmussen, et al.. (2020). Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer. Frontiers in Endocrinology. 11. 614–614. 5 indexed citations

Hjortebjerg, Rikke, Ulrick Espelund, Torben Riis Rasmussen, et al.. (2020). Development of a novel assay for IGFBP-2 complexed with IGF-I and-II in human serum. Growth Hormone & IGF Research. 51. 38–45. 6 indexed citations

Rasmussen, Mads, Silvia Schönenberger, Pia Löwhagen Hendèn, et al.. (2020). Blood Pressure Thresholds and Neurologic Outcomes After Endovascular Therapy for Acute Ischemic Stroke. JAMA Neurology. 77(5). 622–622. 76 indexed citations

10.

Frystyk, Jan, et al.. (2019). PAPP-A activity is increased in cerebrospinal fluid from patients with diabetic polyneuropathy and correlates with peripheral nerve impairment. Growth Hormone & IGF Research. 48-49. 53–59. 5 indexed citations

11.

Espelund, Ulrick, Andrew G. Renehan, Søren Cold, et al.. (2018). Prognostic relevance and performance characteristics of serum IGFBP‐2 and PAPP‐A in women with breast cancer: a long‐term Danish cohort study. Cancer Medicine. 7(6). 2391–2404. 10 indexed citations

12.

Rasmussen, Mads, Ulrick Espelund, Niels Juul, et al.. (2018). The influence of blood pressure management on neurological outcome in endovascular therapy for acute ischaemic stroke. British Journal of Anaesthesia. 120(6). 1287–1294. 36 indexed citations

13.

Espelund, Ulrick, Henning Grønbæk, Gerda Elisabeth Villadsen, et al.. (2015). The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment. Growth Hormone & IGF Research. 25(4). 174–181. 18 indexed citations

14.

Nicoll, Amanda, Gerda Elisabeth Villadsen, Ulrick Espelund, et al.. (2014). Vitamin B₁₂and its binding proteins in hepatocellular carcinoma and chronic liver diseases. Scandinavian Journal of Gastroenterology. 49(9). 1096–1102. 22 indexed citations

15.

Vestergaard, P., Mette Hansen, Jan Frystyk, et al.. (2013). Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults. European Journal of Endocrinology. 170(2). 229–236. 42 indexed citations

16.

Espelund, Ulrick, Klaus Søndergaard, Peter Bjerring, Allan Flyvbjerg, & Jan Frystyk. (2012). Interstitial fluid contains higher in vitro IGF bioactivity than serum: A study utilizing the suction blister technique. Growth Hormone & IGF Research. 22(6). 234–239. 11 indexed citations

17.

Grønbæk, Henning, Peter Holland‐Fischer, Ulrick Espelund, et al.. (2009). Ascites from patients with alcoholic liver cirrhosis contains higher IGF‐I bioactivity than serum. Clinical Endocrinology. 72(5). 625–632. 20 indexed citations

18.

Espelund, Ulrick, Søren Cold, Jan Frystyk, Hans Ørskov, & Allan Flyvbjerg. (2008). Elevated free IGF2 levels in localized, early-stage breast cancer in women. European Journal of Endocrinology. 159(5). 595–601. 16 indexed citations

19.

Espelund, Ulrick, Jens Meldgaard Bruun, Bjørn Richelsen, Allan Flyvbjerg, & Jan Frystyk. (2005). Pro- and mature IGF-II during diet-induced weight loss in obese subjects. European Journal of Endocrinology. 153(6). 861–869. 28 indexed citations

20.

Höybye, Charlotte, Britta Barkeling, Ulrick Espelund, Maria Petersson, & Marja Thorén. (2003). Peptides associated with hyperphagia in adults with Prader–Willi syndrome before and during GH treatment. Growth Hormone & IGF Research. 13(6). 322–327. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact